Press release

Jakarta, 13 June 2022 – After successfully acquiring PT Holi Pharma at the end of 2021, this time PT Pyridam

Jakarta, May 6, 2022 – PT Pyridam Farma Tbk. and its subsidiary (PYFA Group) recorded a significant increase in net

Jakarta, April 5, 2022 – Mundipharma Healthcare Indonesia (MHI), the owner of the Betadine brand in Indonesia, has signed an

Jakarta, 22 March 2022 – Merz Therapeutics GmbH, an affiliate of Merz Pharmaceutical GmbH which excels in neurotoxin field with

Jakarta, February 15, 2022 – In accordance with the commitment of PT. Pyridam Farma Tbk (PYFA) to focus on the

Erik Darius Mardiwidyo and Bedjo Stefanus as Sellers Together with Yenfrino Gunadi and Lee Yan Gwan Representing Buyers Jakarta, August

Jakarta, October 18, 2021 – Getting serious about entering the consumer health market, Pyridam Farma (PYFA) launched a new brand,

Jakarta, August 30, 2021 – PT. Pyridam Farma Tbk with the issuer name PYFA recorded sales of Rp. 105.1 billion

Jakarta, 30 July 2021 – Seeing the number of COVID-19 cases that are still worrying in Indonesia, PT. Pyridam Farma

Supporting the Highest Retail Price (HET) Decision From the Government, PT Pyridam Farma Tbk. Prioritize the Production of Azithromycin and